Our products

A company dedicated to orphan products in the treatment of cancers with an approach targeted on drug resistance, Onxeo designs and develops innovative drugs in rare and orphan diseases. The Company has also developed three drugs based on its innovative  mucoadhesive technology which increases the efficacy or tolerance profile of an active ingredient for its chosen indication. These products have been sold or licensed in 2017.

Orphan oncology products

Other products